PRESS RELEASE published on 09/03/2024 at 10:15, 1 year 4 months ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA declares the number of shares and voting rights in the issued capital. Total shares: 97,330,405. Total voting rights: 165,568,221 Voting Rights Shares Sartorius Stedim Biotech Issued Capital Announcement
BRIEF published on 08/02/2024 at 12:27, 1 year 5 months ago Sartorius Stedim Biotech Announces Share and Voting Rights Update Voting Rights Shares Regulatory Compliance Sartorius Stedim Biotech Issued Capital
PRESS RELEASE published on 08/02/2024 at 12:23, 1 year 5 months ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA declares the total number of shares and voting rights, as of July 31, 2024, in compliance with legal requirements Voting Rights Déclaration Shares Sartorius Stedim Biotech SA July 31 2024
PRESS RELEASE published on 08/02/2024 at 12:22, 1 year 5 months ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA declares the number of shares and voting rights in their issued capital. Details in the announcement Voting Rights Shares AMF Sartorius Stedim Biotech SA French Regulatory News
BRIEF published on 07/19/2024 at 09:55, 1 year 6 months ago Sartorius Stedim Biotech SA: Provision of financial documents Financial Results Investors Sartorius Stedim Biotech First Half Of 2024 Documents Available
PRESS RELEASE published on 07/19/2024 at 09:51, 1 year 6 months ago Sartorius Stedim Biotech SA: Information on Document Availability Sartorius Stedim Biotech Group releases first-half 2024 results report with business development and financial statements. Leading biopharmaceutical partner based in Aubagne, France Financial Statements Biopharmaceutical Industry Sartorius Stedim Biotech Group First-half 2024 Results Aubagne
PRESS RELEASE published on 07/19/2024 at 09:50, 1 year 6 months ago Sartorius Stedim Biotech SA: Information on Document Availability Sartorius Stedim Biotech SA releases information on the availability of documents, including first half 2024 results and financial statements Financial Results Investor Relations Sartorius Stedim Biotech Biopharmaceutical Industry Document Availability
PRESS RELEASE published on 07/19/2024 at 09:37, 1 year 6 months ago Half yearly financial reports and audit reports/limited reviews
PRESS RELEASE published on 07/18/2024 at 18:30, 1 year 6 months ago Half-year results 2024 of SartoriusStedimBiotech Sartorius Stedim Biotech reports half-year results for 2024 with sales revenue of 1,373 million euros and a cautious outlook for the year ahead due to market volatility Volatility Sartorius Stedim Biotech Sales Revenue Outlook Half-year Results
BRIEF published on 07/18/2024 at 18:26, 1 year 6 months ago Sartorius Stedim Biotech Updates Guidance and Shares H1 2024 Results Financial Results Sartorius Stedim Biotech H1 2024 Fiscal Guidance Life Science Sector
Published on 01/30/2026 at 14:00, 6 hours 15 minutes ago CCL to Hold Live Webcast to Discuss Fourth Quarter and Year End 2025 Results, Thursday, February 26, 2026, at 7:30 a.m. ET
Published on 01/30/2026 at 08:35, 11 hours 40 minutes ago Alaska Energy Metals Announces Closing Of Life Offering of Units
Published on 01/30/2026 at 08:00, 12 hours 15 minutes ago Troubadour Resources Intercepts Target Mineralization Near Surface during Phase 1 of the Multi-Phase Drill Program at Senneville Gold-Silver-Copper Property
Published on 01/30/2026 at 02:15, 18 hours ago Canex Metals Announces Success of Gold Basin Take-Over Bid, Extension of the Partial Revocation of the Cease-Trade Order Imposed on Gold Basin, Waiver of All Remaining Conditions, Initiation of the Share Take Up Process, and Mandatory 10-Day Extension
Published on 01/30/2026 at 00:00, 20 hours 15 minutes ago LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies
Published on 01/30/2026 at 20:07, 8 minutes ago Aroundtown SA successfully issued AUD 600 million bonds in two tranches
Published on 01/30/2026 at 18:31, 1 hour 44 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 01/30/2026 at 17:45, 2 hours 30 minutes ago Schneider Electric launches a capital increase reserved for employees
Published on 01/29/2026 at 18:00, 1 day 2 hours ago GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 1 day 2 hours ago LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 1 day 2 hours ago Cegedim generated LFL revenue growth of 1.1% in 2025
